RYR1 and glioblastoma: Our previous studies have shown that elevated CcO activity and the corresponding metabolic switch to OXPHOS are linked to chemoresistance and radioresistance in glioblastoma (GBM), the most aggressive and common type of primary brain tumor [41,42,43,44].